IL11 and breast carcinoma: Several miRNAs have been identified that may inhibit IL-11 in bone metastatic breast cancer cells, including miR-204, miR-211, miR-379 [74] and miR-124 [75], raising the possibility of miRNA-mimicking therapeutics to limit bone loss in metastatic breast cancer.